[1]
V. Singh, “Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Management of Diabetes Mellitus: A Review”, J. Res. Appl. Sci. Biotechnol., vol. 4, no. 6, pp. 106–113, Dec. 2025.